Physical and Chemical Stability of Mycophenolate Mofetil (MMF) Suspension Prepared at the Hospital
Authors
Abstract:
To evaluate the physical and chemical stability of a suspension of mycophenolate mofetil (MMF) prepared in the hospital from commercially available MMF capsules and tablets. Extemporaneous pharmacy was used as a feasible method in this experimental study to prepare suspension form of MMF. Suspension formulations were prepared from both tablets and capsules forms of MMF. Thereafter the stability parameters such as pH, microbial control, thermal and physical stability and particle sizes were evaluated. The amount of MMF, in the suspension was measured at various time points by HPLC. The HPLC method showed that concentration of suspensions prepared from tablets and capsules were 49 mg/mL and 50 mg/mL at time 0, respectively. The effective amount of suspensions prepared from capsules was 101% at time 0, 100% after 7 days, 98% after 14 days, and less than 70% after 28 days. According to the obtained results in this study, capsule-based suspension was stable for as long as 14 days at 5°C. This formulation appears to be clinically acceptable and provides a convenient dosage form for pediatric patients and for adults during the early postoperative period.
similar resources
physical and chemical stability of mycophenolate mofetil (mmf) suspension prepared at the hospital
to evaluate the physical and chemical stability of a suspension of mycophenolate mofetil (mmf) prepared in the hospital from commercially available mmf capsules and tablets. extemporaneous pharmacy was used as a feasible method in this experimental study to prepare suspension form of mmf. suspension formulations were prepared from both tablets and capsules forms of mmf. thereafter the stability...
full textOptimization of Xanthan Gum and Sorbitol Levels in the Mycophenolate Mofetil Powder for Oral Suspension
Background: Mycophenolate mofetil as an immunosuppressive agent is widely administered in patients with kidney disorders and following organ transplantation. The amounts of xanthan gum and sorbitol, as two excipients of mycophenolate mofetil, are influential on the final quality and stability of the suspension. Objective: In this experimental study, we aim to optimize the levels of xanthan gu...
full textMycophenolate mofetil (MMF) in the treatment of epidermolysis bullosa acquisita (EBA) long-term follow-up
E pidermolysis bullosa acquisita (EBA) is an autoimmune mucocutaneous blistering disease. Cutaneous involvement presents with blisters primarily on trauma-prone areas healing with milia. Mucosal involvement can lead to irreversible scarring. The treatment of EBA is based on anecdotal reports in the literature with systemic therapies. Mycophenolate mofetil (MMF) is an immunesuppressing agent tha...
full textBENEFICIAL EFFECT OF LOW DOSE CYCLOSPORINE WITH MMF (MYCOPHENOLATE MOFETIL) IN RENAL ALLOGRAFT RECIPIENTS
Background: Calcineurin inhibitors (CNI) have significantly reduced the incidence of acute rejection. Nephrotoxicity however may contribute to long-term allograft dysfunction. Mycophenolate mofetil (MMF) may allow cyclosporine (CsA) dose reduction without increasing the risk of rejection. Methods: In seventy-eight living unrelated kidney transplant patients with renal dysfunction, we studi...
full textMy Resources
Journal title
volume 11 issue 1
pages 171- 175
publication date 2012-03-11
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023